Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
Evolus (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has announced its participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit in New York City. The event will feature a fireside chat with David Moatazedi, President and CEO of Evolus, scheduled for Thursday, February 27, 2025, from 9:30 AM to 10:00 AM ET.
The fireside chat will be accessible via live webcast on the Investor Relations page of the Evolus website, with replay availability extending 90 days after the event.
Evolus (NASDAQ: EOLS), un'azienda di bellezza performante focalizzata sulla creazione di un portafoglio estetico, ha annunciato la sua partecipazione al TD Cowen 2° Annual Glowing Ahead: Beauty & Wellness Summit a New York City. L'evento includerà una chiacchierata informale con David Moatazedi, Presidente e CEO di Evolus, programmata per giovedì 27 febbraio 2025, dalle 9:30 alle 10:00 ET.
La chiacchierata informale sarà accessibile tramite webcast dal vivo sulla pagina delle relazioni con gli investitori del sito web di Evolus, con la disponibilità di replay che si estenderà per 90 giorni dopo l'evento.
Evolus (NASDAQ: EOLS), una empresa de belleza enfocada en construir un portafolio estético, ha anunciado su participación en el 2° Cumbre Anual Glowing Ahead: Belleza y Bienestar de TD Cowen en la ciudad de Nueva York. El evento contará con una charla informal con David Moatazedi, Presidente y CEO de Evolus, programada para el jueves 27 de febrero de 2025, de 9:30 AM a 10:00 AM ET.
La charla será accesible a través de una transmisión en vivo en la página de Relaciones con Inversores del sitio web de Evolus, con disponibilidad de repetición que se extenderá por 90 días después del evento.
Evolus (NASDAQ: EOLS), 미용 성과에 중점을 둔 회사로, 미적 포트폴리오 구축에 집중하고 있습니다. 이 회사는 뉴욕시에서 열리는 TD Cowen 제2회 Glowing Ahead: 뷰티 & 웰니스 서밋에 참여한다고 발표했습니다. 이 행사는 David Moatazedi Evolus의 회장 겸 CEO와의 대화가 예정되어 있으며, 2025년 2월 27일 목요일 오전 9시 30분부터 10시까지 ET에 진행됩니다.
대화는 Evolus 웹사이트의 투자자 관계 페이지에서 실시간 웹캐스트를 통해 접근할 수 있으며, 이벤트 종료 후 90일 동안 다시 시청할 수 있습니다.
Evolus (NASDAQ: EOLS), une entreprise de beauté axée sur la performance et la création d'un portefeuille esthétique, a annoncé sa participation au 2ème Sommet Annuel Glowing Ahead: Beauté & Bien-être de TD Cowen à New York. L'événement comprendra une discussion informelle avec David Moatazedi, Président et CEO d'Evolus, prévue pour le jeudi 27 février 2025, de 9h30 à 10h00 ET.
La discussion sera accessible via un webinaire en direct sur la page des Relations Investisseurs du site web d'Evolus, avec une disponibilité de replay s'étendant sur 90 jours après l'événement.
Evolus (NASDAQ: EOLS), ein Unternehmen für Leistungsästhetik, das sich auf den Aufbau eines ästhetischen Portfolios konzentriert, hat seine Teilnahme am 2. jährlichen Glowing Ahead: Beauty & Wellness Summit in New York City angekündigt. Die Veranstaltung wird ein informelles Gespräch mit David Moatazedi, Präsident und CEO von Evolus, umfassen, das für Donnerstag, den 27. Februar 2025, von 9:30 bis 10:00 Uhr ET geplant ist.
Das Gespräch wird über einen Live-Webcast auf der Investor-Relations-Seite der Evolus-Website zugänglich sein, mit einer Wiederholungsverfügbarkeit, die sich auf 90 Tage nach der Veranstaltung erstreckt.
- None.
- None.
As part of the event, David Moatazedi, President and CEO of Evolus, will host a fireside chat on Thursday, February 27, 2025, from 9:30 AM – 10:00 AM ET. A live webcast of the fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will remain available for 90 days following the event.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.
Jeuveau® and Nuceiva®, are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220185397/en/
Investors:
Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications
Phone: (248) 202-9267
Email: ir@evolus.com
Media:
Email: media@evolus.com
Source: Evolus
FAQ
When is Evolus (EOLS) presenting at the TD Cowen Beauty & Wellness Summit 2025?
How can investors watch Evolus (EOLS) TD Cowen Summit presentation?
Who will represent Evolus (EOLS) at the 2025 TD Cowen Beauty Summit?
How long will the Evolus (EOLS) TD Cowen Summit webcast replay be available?
